Cardiovascular disease and thyroid function

Area of Science:

• Cardiology
• Endocrinology
• Thyroidology

Background:

• Thyroid hormones critically influence cardiac function, with both hyperthyroidism and hypothyroidism affecting cardiovascular health.
• Existing research links overt thyroid dysfunction to increased mortality and cardiovascular events.
• The impact of subclinical thyroid states on cardiac morbidity and mortality requires further elucidation.

Purpose of the Study:

• To investigate the cardiac implications of subclinical thyroid dysfunction.
• To compare the cardiovascular risks associated with subclinical hyperthyroidism versus subclinical hypothyroidism.
• To inform treatment decisions for subclinical thyroid states based on cardiac risk assessment.

Main Methods:

• Review of existing literature on thyroid function and cardiac outcomes.
• Analysis of cardiovascular risks, including mortality, atrial fibrillation, and heart failure, across the spectrum of thyroid function.
• Evaluation of cardiac structural and functional changes associated with subclinical thyroid states.

Main Results:

• Subclinical hyperthyroidism is linked to increased left ventricular mass and higher risks of mortality and major cardiovascular events.
• Subclinical hypothyroidism is associated with increased cardiac stiffness and a potential increase in myocardial infarction risk.
• Atrial fibrillation risk correlates with thyroid function, increasing from hypothyroidism to hyperthyroidism.

Conclusions:

• Subclinical thyroid states (dysthyroidism) adversely affect cardiac function, morbidity, and mortality.
• Subclinical hyperthyroidism presents a more significant cardiac risk profile than subclinical hypothyroidism.
• These findings suggest a more aggressive treatment approach for subclinical hyperthyroidism to mitigate cardiac risks.